Other Key Myeloma CAR T-Cell Therapy Data From ASH 2025

Krina K. Patel, MD, MSc, and Matthew J. Frigault, MD, summarize additional CAR T-cell therapy data in multiple myeloma presented at the 2025 ASH Annual Meeting and Exposition. They discuss updates from ongoing trials, real-world evidence, and evolving safety insights. Patel and Frigault highlight how these data continue to refine clinical expectations for CAR T-cell therapy.